Zdrowie i gospodarka · 23/08/2024

FDA Refuses to Approve New Drug Application for ITCA 650 by Intarcia Therapeutics, Inc.

The US Food and Drug Administration (FDA) has issued a refusal to approve a new drug application for ITCA 650, a diabetes treatment developed by Intarcia Therapeutics, Inc., citing concerns over the drug's safety for its intended use.